From Rx Drug Abuse & Heroin Summit
Public confusion between cannabidiol (CBD) and tetrahydrocannabinol (THC) is stymying essential medical progress in the treatment of a range of illnesses.
Changes to medical marijuana laws, use of PDMPs state-by-state, and access to naloxone were among the legal topics covered during a breakout session Thursday at the Rx Summit.
The final plenary session at the Rx Drug Abuse & Heroin Summit served as a reminder that any location where persons with opioid use disorders can be found can offer effective evidence-based care.
Efforts to overcome barriers to working with tribal nations in New Mexico and a program to prevent overdoses among inmates recently released in Philadelphia were among the topics covered during…